MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - Role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation

Molecular and Cellular Endocrinology

Volumn 374, Issue 1-2, 2013, Pages 117-124

  Diniz, Gabriela Placoná ^a   Takano, Ana Paula ^a   Barreto Chaves, Maria Luiza Morais ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alpha myosin heavy chain; Beta myosin heavy chain; Cardiac hypertrophy; MicroRNA 208a; Thyroid hormone; Type 1 Angiotensin II receptor

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; LIOTHYRONINE; MESSENGER RNA; MICRORNA; MICRORNA 208A; MICRORNA 208B; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; THYROXINE; UNCLASSIFIED DRUG;

ALPHA MYOSIN HEAVY CHAIN GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOWN REGULATION; GENE EXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HYPERTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; THYROXINE BLOOD LEVEL; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; GENE EXPRESSION REGULATION; HYPERTHYROIDISM; MALE; MICRORNAS; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; PRIMARY CELL CULTURE; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; THYROID GLAND; THYROID HORMONES;

EID: 84878710779     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.04.010     Document Type: Article

References (49)

1. Adam O., Löhfelm B., Thum T., Gupta S.K., Puhl S.L., Schäfers H.J., Böhm M., Laufs U. Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res. Cardiol. 2012, 107:278.
2. Barreto-Chaves M.L., Heimann A., Krieger J.E. Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes. Braz. J. Med. Biol. Res. 2000, 33:661-664.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Bartel D.P., Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 2004, 5:396-400.
5. Callis T.E., Pandya K., Seok H.Y., Tang R.H., Tatsuguchi M., Huang Z.P., Chen J.F., Deng Z., Gunn B., Shumate J., et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 2009, 119:2772-2786.
6. Carneiro-Ramos M.S., Diniz G.P., Nadu A.P., Almeida J., Vieira R.L., Santos R.A., Barreto-Chaves M.L. Blockage of Angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res. Cardiol. 2010, 105:325-335.
7. Cheng Y., Ji R., Yue J., Yang J., Liu X., Chen H., Dean D.B., Zhang C. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?. Am. J. Pathol. 2007, 170:1831-1840.
8. Dillmann W. Cardiac hypertrophy and thyroid hormone signaling. Heart Fail. Rev. 2010, 15:125-132.
9. Diniz G.P., Carneiro-Ramos M.S., Barreto-Chaves M.L. Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy. Pflugers Arch. 2007, 454:75-81.
10. Diniz G.P., Carneiro-Ramos M.S., Barreto-Chaves M.L. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway. Basic Res. Cardiol. 2009, 104:653-670.
11. 3 on AT1R expression. J. Mol. Endocrinol. 2012, 49:11-20.
12. Divakaran V., Mann D.L. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ. Res. 2008, 103:1072-1083.
13. Fazio S., Palmieri E.A., Lombardi G., Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog. Horm. Res. 2004, 59:31-50.
14. Gupta M.P. Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J. Mol. Cell. Cardiol. 2007, 43:388-403.
15. Gupta S., Das B., Sen S. Cardiac hypertrophy: mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 2007, 9:623-652.
16. Hanatani A., Yoshiyama M., Kim S., Omura T., Toda I., Akioka K., Teragaki M., Takeuchi K., Iwao H., Takeda T. Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J. Mol. Cell. Cardiol. 1995, 27:1905-1914.
17. Hu L.W., Benvenuti L.A., Liberti E.A., Carneiro-Ramos M.S., Barreto-Chaves M.L. Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R1473-R1480.
18. Izumo S., Nadal-Ginard B., Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc. Natl. Acad. Sci. USA 1988, 85:339-343.
19. Jeppesen P.L., Christensen G.L., Schneider M., Nossent A.Y., Jensen H.B., Andersen D.C., Eskildsen T., Gammeltoft S., Hansen J.L., Sheikh S.P. Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes. Br. J. Pharmacol. 2011, 164:394-404.
20. Kahaly G.J., Dillmann W.H. Thyroid hormone action in the heart. Endocr. Rev. 2005, 26:704-728.
21. Kenessey A., Ojamaa K. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J. Biol. Chem. 2006, 281:20666-20672.
22. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 2001, 344:501-509.
23. Kobori H., Ichihara A., Suzuki H., Takenaka T., Miyashita Y., Hayashi M., Saruta T. Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. Am. J. Physiol. 1997, 273:H593-H599.
24. Kobori H., Ichihara A., Miyashita Y., Hayashi M., Saruta T. Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. J. Endocrinol. 1999, 160:43-47.
25. Kuzman J.A., O'Connell T.D., Gerdes A.M. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy. Endocrinology 2007, 148:3477-3484.
26. Landenson P.W., Sherman S.I., Baughman K.L., Ray P.E., Feldman A.M. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. PNAS USA 1992, 89:5251-5255.
27. Liang F., Webb P., Marimuthu A., Zhang S., Gardner D.G. Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes. J. Biol. Chem. 2003, 278:15073-15083.
28. Machackova J., Liu X., Lukas A., Dhalla N.S. Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes. Mol. Cell. Biochem. 2004, 261:271-278.
29. Montgomery R.L., Hullinger T.G., Semus H.M., Dickinson B.A., Seto A.G., Lynch J.M., Stack C., Latimer P.A., Olson E.N., van Rooij E. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 2011, 124:1537-1547.
30. Morkin E. Control of cardiac myosin heavy chain gene expression. Microsc. Res. Technol. 2000, 50:522-531.
31. Mourouzis I., Forini F., Pantos C., Iervasi G. Thyroid hormone and cardiac disease: from basic concepts to clinical application. J. Thyroid Res. 2011, 2011:958626.
32. Pantos C., Paizis I., Mourouzis I., Moraitis P., Tzeis S., Karamanoli E., Mourouzis C., Karageorgiou H., Cokkinos D.V. Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning. Horm. Metab. Res. 2005, 37:500-504.
33. Plasterk R.H. Micro RNAs in animal development. Cell 2006, 124:877-881.
34. Prada P., Okamoto M.M., Furukawa L.N., Machado U.F., Heimann J.C., Dolnikoff M.S. High- or low-salt diet from weaning to adulthood: effect on insulin sensitivity in Wistar rats. Hypertension 2000, 35:424-429.
35. Pulakat L., Aroor A.R., Gul R., Sowers J.R. Cardiac insulin resistance and microRNA modulators. Exp. Diab. Res. 2012, 2012:654904.
36. Sadoshima J., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ. Res. 1993, 73:413-423.
37. Sayed D., Hong C., Chen I.Y., Lypowy J., Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res. 2007, 100:416-424.
38. Schlüter K.D., Wenzel S. Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks. Pharmacol. Ther. 2008, 119:311-325.
39. Shende P., Plaisance I., Morandi C., Pellieux C., Berthonneche C., Zorzato F., Krishnan J., Lerch R., Hall M.N., Rüegg M.A., Pedrazzini T., Brink M. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 2011, 123:1073-1082.
40. Tatsuguchi M., Seok H.Y., Callis T.E., Thomson J.M., Chen J.F., Newman M., Rojas M., Hammond S.M., Wang D.Z. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 2007, 42:1137-1141.
41. Thum T., Galuppo P., Wolf C., Fiedler J., Kneitz S., van Laake L.W., Doevendans P.A., Mummery C.L., Borlak J., Haverich A., Gross C., Engelhardt S., Ertl G., Bauersachs J. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007, 116:258-267.
42. Thum T., Catalucci D., Bauersachs J., et al. MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc. Res. 2008, 79:562-570.
43. Thum T., Gross C., Fiedler J., Fischer T., Kissler MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984.
44. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA 2006, 103:18255-18260.
45. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579.
46. van Rooij E., Marshall W.S., Olson E.N. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ. Res. 2008, 103:919-928.
47. van Rooij E., Quiat D., Johnson B.A., Sutherland L.B., Qi X., Richardson J.A., Kelm R.J., Olson E.N. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell. 2009, 17:662-673.
48. Wang N., Zhou Z., Liao X., Zhang T. Role of microRNAs in cardiac hypertrophy and heart failure. IUBMB Life 2009, 61:566-571.
49. Xiang F., Sakata Y., Cui L., Youngblood J.M., Nakagami H., Liao J.K., Liao R., Chin M.T. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H1997.